SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-16-007725
Filing Date
2016-07-29
Accepted
2016-07-29 07:02:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 EVOKE PHARMA, INC. p16-1638sc13g.htm SC 13G 81264
  Complete submission text file 0000902664-16-007725.txt   82770
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Subject) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87872 | Film No.: 161791944
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G